fda warning compounding semaglutide september 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs MadeMed Review: Compounded GLP-1 Pricing,

Nihon Bunka Kagakusha

None of these adjustments are large 0.20.4 g/kg shifts inside the same band but they are the difference between protecting lean mass and losing it

H.AgerberthB.OdebergJ.BergmanT.OlssonB.SalcedoR

however, those who persisted with the medication coverage experienced weight losses comparable with those shown in corresponding clinical trials. And in a paper published in 2023, researchers found that while significant weight loss was achievable with GLP-1s among type 2 diabetes patients, the average weight reduction was relatively modest, 2.2% after 72 weeks of being on the medications

In the case of obese individuals, an elevated BMI has been linked to increased interactional displacement, primarily stemming from the continuous movement of the skin and subcutaneous adiposity [31]

[1] [2] In that trial, diarrhoea was reported in a meaningful proportion of participants, with rates generally higher at elevated doses and during escalation periods